U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07586735) titled 'A Novel Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplant in Patients Aged >= 40 Years Old With Severe Aplastic Anemia' on May 08.
Brief Summary: The goal of this prospective, multicenter, single arm observational study is to evaluate the efficacy and safety of the BFCA regimen in >= 40 years old SAA patients undergoing haplo-HSCT.
Study Start Date: May, 2026
Study Type: OBSERVATIONAL
Condition:
Busulfan 0.8 mg/kg/q6h (Days -8 to -7) Fludarabine 30mg/m2/Day (Days -6 to -2) Cyclophosphamide 25 mg/kg/Day and r-ATG 2.5 mg/kg/Day (Days -5 to -2)
Intervention:
OTHER: BFC conditiong regimen
Conditioning regi...